Phillip Angart Center for Drug Evaluation and Research, Office of Product Quality, Office of Biotechnology Products, Division of Biotechnology Review and Research II U.S. Food and Drug Administration Biography Publications Institution JoVE Articles Phillip Angart has not added a biography. If you are Phillip Angart and would like to personalize this page please email our Author Liaison for assistance. Publications Purificazione e analisi di un anticorpo monoclonale da cellule ovaio Cesster cinese utilizzando un sistema microbioreante automatizzato Sai Rashmika Velugula-Yellela1, David N. Powers1, Phillip Angart1, Anneliese Faustino1, Talia Faison1, Casey Kohnhorst1, Erica J. Fratz-Berilla1, Cyrus D. Agarabi1 1Center for Drug Evaluation and Research, Office of Product Quality, Office of Biotechnology Products, Division of Biotechnology Review and Research II, U.S. Food and Drug Administration JoVE 58947 Bioengineering Uso di High-Throughput Microbioreactor sistema automatizzato per la produzione del modello IgG1 in cellule CHO Sai Rashmika Velugula-Yellela1, Casey Kohnhorst1, David N. Powers1, Nicholas Trunfio1, Anneliese Faustino1, Phillip Angart1, Erica Berilla1, Talia Faison1, Cyrus Agarabi1 1Center for Drug Evaluation and Research, Office of Product Quality, Office of Biotechnology Products, Division of Biotechnology Review and Research II, U.S. Food and Drug Administration JoVE 58231 Bioengineering
Purificazione e analisi di un anticorpo monoclonale da cellule ovaio Cesster cinese utilizzando un sistema microbioreante automatizzato Sai Rashmika Velugula-Yellela1, David N. Powers1, Phillip Angart1, Anneliese Faustino1, Talia Faison1, Casey Kohnhorst1, Erica J. Fratz-Berilla1, Cyrus D. Agarabi1 1Center for Drug Evaluation and Research, Office of Product Quality, Office of Biotechnology Products, Division of Biotechnology Review and Research II, U.S. Food and Drug Administration JoVE 58947 Bioengineering
Uso di High-Throughput Microbioreactor sistema automatizzato per la produzione del modello IgG1 in cellule CHO Sai Rashmika Velugula-Yellela1, Casey Kohnhorst1, David N. Powers1, Nicholas Trunfio1, Anneliese Faustino1, Phillip Angart1, Erica Berilla1, Talia Faison1, Cyrus Agarabi1 1Center for Drug Evaluation and Research, Office of Product Quality, Office of Biotechnology Products, Division of Biotechnology Review and Research II, U.S. Food and Drug Administration JoVE 58231 Bioengineering
